Fluoxetine stimulates glial cell line-derived neurotrophic factor synthesis and release in cultured rat astrocytes
Xiaobin Zhang, Zhijun Zhang, Chunming Xie
Abstract
Xiaobin Zhang, Zhijun Zhang, Chunming Xie
Abstract
Objective To explore the effects of fluoxetine on glial cell line-derived neurotrophic factor (GDNF) synthesis and release in cultured rat astrocytes. Methods The MTT assay were used to evaluate cell viability, the expression of GDNF mRNA were detected with real-time PCR. The level of GDNF in cell-conditioned media was measured using enzyme linked immunosorbent assay (ELISA). Results (1) The cell viability was significantly decreased when the concentration of fluoxetine was more than 35 μmol/L (P<0.01 or P<0. 05). (2) When the cells were treated with the 10 μmol/L fluoxetine for different time, the level of GDNF in cell-conditioned media of the 48 hour group [(68±13) fg/L] was significantly higher than that of the 0, 6, 12, 24 hour group [(32±11), (34±12), (41±17) and (45±13) fg/L] (P<0.01). (3) When the cells were treated with the different concentration of fluoxetine for 48 hour, the level of GDNF in cell-conditioned media of 10 μmol/L group[(64±17) fg/L] was significantly higher than that of 0 μmol/L and 1 μmol/L groups[(39±15), (39±18) fg/L] (P<0.05). (4) When the cells were treated at a range of concentrations of fluoxetine for 48 hour, the GDNF was also significantly released by astrocytes after with draual of fluoxetine for 24 hours, (P<0.01or P<0.05). (5) After the cells were treated with the different concentrations of fluoxetine for 24 hour, the expression of GDNF mRNA in 10 μmol/L and 20 μmol/L groups [(0.008 1±0.001 1), (0.006 3±0.000 3)] were significantly higher than that in 0 μmol/L, 1 μmol/L and 5 μmol/L groups [(0.003 1±0.000 7), (0.003 9±0.000 3),(0.004 1±0.000 2)]. Conclusion The results suggest that fluoxetine could stimulate GDNF release from astrocytes, which might underlie it's neuroprotective properties. Key words: Fluoxetine; Astrocytes; Glial cell line-derived neurotrophic factor
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effects of fluoxetine on glial cell line-derived neurotrophic factor (GDNF) synthesis and release in cultured rat astrocytes. Methods The MTT assay were used to evaluate cell viability, the expression of GDNF mRNA were detected with real-time PCR. The level of GDNF in cell-conditioned media was measured using enzyme linked immunosorbent assay (ELISA). Results (1) The cell viability was significantly decreased when the concentration of fluoxetine was more than 35 μmol/L (P<0.01 or P<0. 05). (2) When the cells were treated with the 10 μmol/L fluoxetine for different time, the level of GDNF in cell-conditioned media of the 48 hour group [(68±13) fg/L] was significantly higher than that of the 0, 6, 12, 24 hour group [(32±11), (34±12), (41±17) and (45±13) fg/L] (P<0.01). (3) When the cells were treated with the different concentration of fluoxetine for 48 hour, the level of GDNF in cell-conditioned media of 10 μmol/L group[(64±17) fg/L] was significantly higher than that of 0 μmol/L and 1 μmol/L groups[(39±15), (39±18) fg/L] (P<0.05). (4) When the cells were treated at a range of concentrations of fluoxetine for 48 hour, the GDNF was also significantly released by astrocytes after with draual of fluoxetine for 24 hours, (P<0.01or P<0.05). (5) After the cells were treated with the different concentrations of fluoxetine for 24 hour, the expression of GDNF mRNA in 10 μmol/L and 20 μmol/L groups [(0.008 1±0.001 1), (0.006 3±0.000 3)] were significantly higher than that in 0 μmol/L, 1 μmol/L and 5 μmol/L groups [(0.003 1±0.000 7), (0.003 9±0.000 3),(0.004 1±0.000 2)]. Conclusion The results suggest that fluoxetine could stimulate GDNF release from astrocytes, which might underlie it's neuroprotective properties. Key words: Fluoxetine; Astrocytes; Glial cell line-derived neurotrophic factor
Key concepts: Glial cell line-derived neurotrophic factor, Neurotrophic factors, Fluoxetine, Viability assay, MTT assay, Cell culture, Molecular biology, Chemistry